ABIVAX
Abivax s Covid-19 Phase 2b/3 miR-AGE trial with ABX464 declared Research National Priority by the French government s Clinical Trial Council
DGAP-News: ABIVAX / Key word(s): Study
Abivax s Covid-19 Phase 2b/3 miR-AGE trial with ABX464 declared Research National Priority by the French government s Clinical Trial Council
22.12.2020 / 19:30
The issuer is solely responsible for the content of this announcement.
Abivax s Covid-19 Phase 2b/3 miR-AGE trial with ABX464 declared Research National Priority by the French government s Clinical Trial Council
Research National Priority has priority for patient enrollment in clinical trials for an accelerated review and approval process with the French regulatory authorities
Effective Covid-19 treatments very much needed because optimal vaccination coverage of millions of individuals and public acceptance will take time
Search jobs 22-Dec-2020 Abivax s Covid-19 Phase 2b/3 miR-AGE trial with ABX464 declared Research National Priority by the French government s Clinical Trial Council
DGAP-News: ABIVAX / Key word(s): Study
22.12.2020 / 19:30
The issuer is solely responsible for the content of this announcement.
Abivax s Covid-19 Phase 2b/3 miR-AGE trial with ABX464 declared Research National Priority by the French government s Clinical Trial Council
Research National Priority has priority for patient enrollment in clinical trials for an accelerated review and approval process with the French regulatory authorities
Effective Covid-19 treatments very much needed because optimal vaccination coverage of millions of individuals and public acceptance will take time